# Bristol-Myers Squibb Company (BMY) — Q1-2015 Earnings Results

**Report date:** 2015-04-28 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q1-2015

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Down 0.95%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.71 | N/A | +40.87% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a positive outlook regarding their product pipeline. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They expressed confidence in ongoing clinical trials and pipeline development.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Bristol Myers Squibb's earnings report showed a strong EPS beat, indicating better-than-expected profitability. However, the stock fell by 0.95%, possibly due to the lack of revenue data and forward guidance. Investors may be cautious as the company navigates its pipeline and market conditions.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q1-2015_